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Abstract: Adjustment disorders (AD) and complicated grief (CG) are serious mental 
conditions that have a high prevalence and are associated with significant impairments in social 
and work functioning. Recently, these categories have been better specified in the new ICD-11 
proposal. Empirical research on the efficacy of treatments for these problems is scarce. This 
study aims to offer long-term efficacy data from a between-groups controlled study that 
compares two treatment conditions (AD-protocol applied in a traditional way: N= 18; and the 
same protocol supported by virtual reality-VR-: N =18) and a waiting list (WL) control group 
(N =18). Both treatment conditions resulted in statistically significant improvements on both 
primary and secondary outcome measures, with large effect sizes, and this improvement did not 
occur in the WL. These changes were maintained in both treatment conditions in the medium 
(6-month) and long term (12-month follow-up). Larger effect sizes were achieved in the VR 
condition in the long term. Furthermore, clinically significant change estimations on the primary 
outcome measures showed an advantage for the VR condition This is the first controlled study 
to compare a traditional face-to-face protocol for the treatment of stress-related disorders to the 
same protocol supported by VR and a WL control group. 
Key Practitioner Message: 
 A CBT protocol has been designed and developed for AD. 
 This protocol applied traditionally and with VR was more effective than a WL. 
 Changes were maintained in both treatment conditions at 6- and 12-month follow-ups. 
 VR seems to be a promising tool to deliver the elaboration/exposure component for AD 
and CG. 
Key words: Adjustment Disorder, Complicated Grief, Prolonged Grief Disorder, CBT, Virtual 
reality, Positive psychology strategies.  
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Adjustment disorders (AD) and complicated grief (CG) are two categories that 
have traditionally been poorly specified by the DSM and ICD-10. In the last edition 
(DSM-5, APA, 2013), AD was classified for the first time in the category of “Trauma 
and stress related disorders”, along with another important disorder, posttraumatic stress 
disorder (PTSD). However, the DSM-5 has been criticized for the lack of specific 
symptom descriptions and the difficulty of distinguishing between AD and normal 
adaptive stress reactions (Casey, 2014). In the case of CG, DSM-5 has introduced 
criteria for persistent complex bereavement disorder also categorized as one of the 
“other specified trauma- and stressor-related disorder” while the CG, was placed in the 
Research section (III) as a condition requiring further study. 
More recently, the ICD-11 work group proposed that these two diagnostic 
categories to be included for the first time in the new chapter “Disorders Specifically 
Associated with Stress” and have provided a clearer definition of symptoms (Maercker 
et al., 2013). AD is defined as a maladaptive reaction to a negative stressful life event or 
life change, characterized by symptoms of preoccupation, such as excessive worry, 
recurrent and distressing thoughts about the stressor, or constant rumination about its 
implications. There is a failure to adapt, i.e., the symptoms interfere with everyday 
functioning, such as difficulties concentrating or sleep disturbances resulting in 
performance problems. These symptoms can also be associated with loss of interest in 
work, social life, caring for others, leisure activities, resulting in impairments in social 
or occupational functioning. Prolonged grief disorder is defined as a disturbance in 
which, following the death of a person close to the bereaved, there is a persistent and 
pervasive yearning or longing for the deceased, or a persistent preoccupation with the 
deceased that extends for an abnormally long period beyond the expected social and 
cultural norms (e.g., at least 6 months, or longer, depending on cultural and contextual 
factors) and is sufficiently severe to cause significant impairment in the person’s 
functioning. The response can also be characterized by difficulties in accepting the 
death, feeling that one has lost a part of one’s self, anger about the loss, guilt, or 
difficulty in engaging with social or other activities. In this article, we use the term CG 
to refer to the Prolonged Grief disorder proposed by the ICD-11. Participants with 
persistent complex bereavement disorder were not included (Boelen &Smid, 2017). 
However, at the time the present study was conducted, the classifications 
mentioned above were not available. Therefore, the DSM-IV-TR (APA, 2000) and 
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ICD-10 (WHO, 1992) criteria for AD were followed. In the case of CG, according to 
the ICD-10 classification, we considered it as an AD. Specifically, the ICD-10 allows 
the codification of bereavement as an AD when the reaction to the death of a loved one 
is considered abnormal because of its manifestations or content, or when this reaction is 
still intense more than 6 months after the death. 
AD is among the diagnoses most widely used by psychiatrists and psychologists 
worldwide (Maercker et al., 2013). Recently, Yaseen (2017) estimated AD prevalence 
data in outpatient psychiatric clinics in values around 11%. Regarding CG, a recent 
systematic review and meta-analysis on the prevalence of prolonged grief disorder in 
adult bereavement conducted by Lundorff, Holmgren, Farver-Vestergaard and 
O’Connor. (2017) revealed a pooled prevalence of 9.8%. In addition to the high 
prevalence of AD (Carta, Balestrieri, Murru & Hardoy, 2009), this problem is 
associated with significant impairment in social and work functioning, causing a high 
percentage of sick leave (Van der Klink, Blonk, Schene & van Dijk, 2003). Furthermore, 
AD is the most common diagnosis in people with self-harm behaviors (Casey, 2009); up 
to 25% of adolescents with AD perform suicidal behaviors (Pelkonen, Marttunen, 
Henriksson & Loongvist, 2007), with this percentage reaching 60% in adults 
(Kryzhananovskaya & Canterbury, 2001). Results obtained more recently by Casey, 
Jabbar, O’Leary and Doherty (2015) indicate that AD is a potentially serious condition 
that can present life-threatening features, with similar percentages of patients with AD 
and depressive episodes reporting suicidal ideation or behavior. In addition, the 
occurrence of suicidality at a lower symptom score in AD suggests that this group is 
more vulnerable. Along the same lines, CG is associated with intense suffering and the 
risk of developing mental and physical health problems (Stroebe, Schut & Stroebe, 
2007), increasing the risk of hospitalization (Li, Laursen, Precht, Olsen, & Mortensen, 
2005), and being associated with medical comorbidity (Prigerson et al., 1997), 
suicidality (Latham & Prigerson, 2004), and greater work and social impairment. It is a 
debilitating and chronic disorder (Simon et al., 2007). 
Therefore, evidence-based psychological treatments for AD and CG are needed. 
Few intervention studies are available on AD (Casey & Bailey, 2011). In addition, the 
few studies conducted using between-group designs have been carried out from 
different therapeutic approaches: mirror therapy (González-Jaimes & Turnbull-Plaza, 
2003), problem solving and temporal contingency approach (van der Klink et al., 2003), 
CBT (Sterinhardt & Dolbier; 2008), brief group psychodynamic therapy (Ben-Itzhak et 
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al., 2012), Body-Mind-Spirit psychotherapy (Hsiao et al., 2014), meditation training 
(Srivastava, Talukdar & Lahan, 2011);). Although overall they reported a decrease of 
symptoms, many of them have important methodological limitations. Some use 
techniques with no empirical support (e.g., Hsiao et al., 2014), whereas others do not 
describe the samples used sufficiently (e.g., González-Jaimes & Turnbull-Plaza, 2003), 
and/or they do not include control groups (Ben-Itzhak et al., 2012) or the ones they use 
are inadequate (e.g., Srivastava et al., 2011). Finally, other studies focus on a very 
restrictive objective, such as limiting the duration of sick leaves (van der Klink et al., 
2003), or their intervention proposal is limited to counseling or discussion about 
possible problem-solving strategies, and/or the sample is composed of university 
students (Sterinhardt & Dolbier, 2008). 
Regarding treatment for CG, Neimeyer has a number of publications about 
treatments for this problem. His approach (Neimeyer, 2000) focuses on the 
reconstruction of meaning after loss (Neimeyer & Currier, 2009). Results from the 11 
studies included in the review study by Currier, Holland and Neimeyer (2010) showed 
that CBT-based interventions were more effective than other commonly practiced 
therapies. However, after accounting for the influence of researcher allegiance, 
differences between therapies became smaller and were no longer statistically 
significant. Compared to no-treatment control groups, CBT-based interventions 
produced benefits immediately after intervention, but they did not yield statistically 
significant overall effects at follow-up. Therefore, the authors concluded that there is 
preliminary evidence for the helpfulness of CBT-based interventions for bereaved 
persons, but studies on the relative efficacy of different cognitive-behavioral change 
strategies, as well as other orientations, are still needed. As indicated in more recent 
review studies (Shear, 2015; Crunk, Kurke & Robinson III, 2017), several randomized 
controlled trials have shown that a short-term approach called complicated grief 
treatment is the treatment that has been most extensively studied so far (e.g., Boelen, 
Keijser, vand den Hout & van den Hout, 2007; Bryant, Kenny, Joscelyne, et al., 2014; 
Shear, Frank, Houck & Reynolds, 2005; Shear et al., 2014). The treatment includes two 
main objectives: restoring effective functioning by generating enthusiasm and creating 
plans for the future and helping patients find a way to think about the death without 
having intense feelings of anger, guilt or anxiety (Shear, 2015). 
Based on the aforementioned, we can conclude that no specific protocol exists 
for AD because none of the experimental studies reviewed above propose a treatment 
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specifically designed for this problem. Therefore, we developed an AD-protocol to treat 
AD and CG (Botella, Baños & Guillén, 2008) that includes CBT techniques and 
positive psychology strategies. Furthermore, it is supported by virtual reality (VR).  
Several systematic reviews (Freeman et al., 2017; Gregg & Tarrier, 2007; McCann et 
al., 2014; Meyerbroker & Emmelkamp, 2010) and a number of meta-analytic studies 
(Opriş et al., 2011; Parsons & Rizzo, 2008; Powers & Emmelkamp, 2008) concluded 
that the most well-established finding is that VR exposure-based treatments can reduce 
anxiety disorders and PTSD. In the case of Opris et al. (2011) and Morina et al. (2015), 
the authors also found that VR has a powerful real-life impact, similar to that of the 
classical evidence-based treatments, and good stability in the results over time. 
Additionally, meta-analyses and systematic reviews specifically addressed to stress-
related disorders (mainly PSD) (Botella, Serrano, Baños & Garcia-Palacios, 2015; 
Gonçalves, Pedrozo, Coutinho, Figueira & Ventura, 2012; Motraghi, Seim, Meyer & 
Morissete, 2014), have also shown the usefulness of  VR environments for applying the 
exposure technique in treating these disorders. Finally, other exposure-based 
approaches, such as EMDR, have also shown their efficacy in the treatment of 
distressful experiences that failed to meet the criteria for PTSD (Cvetek (2008).  
The present study uses the EMMA’s World VR system (Botella et al., 2006) to 
apply elaboration/exposure technique. This system was developed as part of a European 
project (Engaging Media for Mental Health Applications, IST-200-39192). EMMA’s 
World is an open and flexible adaptive VR device that adjusts its contents to the 
patient’s needs. This flexibility makes it possible to use this VR system to treat CG and 
a variety of AD cases, regardless of the stressful event that triggered them (e.g., a 
divorce, a firing, a serious disease, economic problems, etc.). Preliminary efficacy data 
for this protocol already exist in two case studies (Andreu-Mateu, Botella, Quero, 
Guillén & Baños, 2012; Botella, Osma, García-Palacios, Guillén & Baños, 2008), and 
in a between-group study (Baños et al., 2011) that included participants with different 
stress-related disorders (PTSD, CG and AD). The results showed that traditional CBT 
programs were equally as effective as a CBT program supported by EMMA’s World. 
However, no control group was included in this study, and no follow-up data were 
available. The aim of the present study is to offer long-term efficacy data from two AD-
treatment protocols (an AD-treatment protocol supported by VR -EMMA’s World- and 
an AD-protocol applied in a traditional - face-to face way) compared to a waiting list 
control group in an RCT. A secondary aim is to explore and compare both ways of 
6 
 
delivering the AD-protocol. First, it is hypothesized that both treatment conditions will 
significantly reduce primary symptoms of AD and CG, compared to the waiting list 
control group. Second, both treatment conditions will show efficacy and no statistically 
significant differences will be found between them. Finally, the therapeutic gains 
obtained in both conditions will be maintained at 1-year follow-up.  
2. METHOD 
2.1. Design  
A three-armed single-blind RCT was conducted. Participants were randomized 
into three groups: 1) EMMA condition, 2) Traditional condition, and 3) Waiting list 
(WL) control condition. Participants in the control group were randomly assigned to one 
of the two treatment conditions after spending time on the waiting list (6 weeks) for 
ethical reasons. This study was conducted following the CONSORT statement 
(Consolidated Standards of Reporting Trials, http://www.consort-statement.org) and 
received approval from the Ethics Committee of Universitat Jaume I (Castellón, Spain) 
Participants were assessed at pre-treatment, post-treatment, and 6- and 12-month 
follow-ups. Figure 1 shows the flowchart for the study.   
2.2. Participants  
This study was conducted at the Emotional Disorders Clinic at Universitat 
Jaume I in Castellón and Valencia (Spain). Participant recruitment was carried out 
through advertisements (mail, posters, radio, and press) about the study developed in 
our clinic. Other participants came to seek help at our clinic, and others were referred 
from public mental health services.  
Inclusion criteria were: age between 18 and 65 years old; meeting AD criteria 
according to the DSM-IV-TR (APA, 2000) and ICD-10 (WHO, 1992) or Prigerson and 
Jacobs’ (2001) criteria for CG. Exclusion criteria were: current alcohol or drug 
dependence or abuse; psychosis or a severe personality disorder; a severe organic 
illness; malingering, showing obvious “secondary gains” (e.g., financial compensation, 
avoidance of work, etc.); and currently being treated in a similar treatment program. 
Receiving pharmacological treatment was not an exclusion criterion, but any increase 
and/or change in the medication during the study period implied the participant’s 
exclusion from subsequent analyses. A decrease in pharmacological treatment was 
accepted. In the present study, as we have mentioned before, following ICD-10 criteria, 
cases of CG were considered an AD subtype, and patients with both diagnoses were 
included. Additionally, Prigerson and Jacobs’ (2001) criteria were considered in the CG 
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cases. Table 1 shows participants’ sociodemographic and clinical data for each group 
and for the total sample. The type of stressful event experienced by the AD patients 
was: break-up relationship or divorce (n=14; 25.93%), own or family health problems 
(n=11; 20.37%), work/study problems (n=11; 20.37%), family problems (n=12; 
21.82%), or grief (n=6; 10.91%). 
INSERT FIGURE 1 ABOUT HERE 
 
INSERT TABLE 1 ABOUT HERE 
2.3. Measures 
2.3.1. Diagnostic 
Diagnostic Interview Adjustment Disorder (Andreu-Mateu, Botella, Baños & 
Quero, 2008). This semi-structured interview was developed by our research team for 
the assessment of AD, based on data available in the literature, the diagnostic criteria 
from both the ICD-10 and the DSM-IV-TR, and the SCID-IV interview (First, Spitzer, 
Gibbon and Williams 1999). The presence and severity of 28 symptoms related to AD 
are assessed on a scale from 0 to 8 (0= Nothing at all; 8= Very severe). This interview is 
currently undergoing a validation process. An optional section for evaluating Prigerson 
and Jacobs’ (2001) criteria for complicated grief is also included. In the present study, 
the number of symptoms was analyzed as an outcome measure.  
2.3.2. Primary outcome measures 
Inventory of Complicated Grief (ICG) (Prigerson et al. 1995). This instrument 
assesses the symptoms that characterize complicated grief, and it differentiates 
individuals who suffer from complicated grief symptoms, cannot adapt adequately to 
the death of a loved one, and present important functional alterations in their daily lives 
from those who are following a normal bereavement process. It consists of 19 items 
scored on a 5-point Likert scale ranging from 0 (“Never”) to 4 (“Always”). Scores 
above 25 indicate a significantly higher degree of interference in general, mental, and 
social functioning, worse physical health, and higher levels of physical pain. Prigerson 
et al. (1995) obtained high internal consistency, test-retest reliability, and convergent 
and criterion validity.  
Adaptation of the ICG, Inventory of Stress and Loss (ISL) (Quero, Mor, Molés, 
Rachyla, Baños & Botella, in preparation), in order to measure stress and loss 
symptoms derived from stressful situations. This instrument has been adapted by our 
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team to better assess the stressful situations that negatively interfere with people’s lives. 
The adaptation was based on the assumption that a stressful life event always entails 
some kind of loss for the person. The instrument was made up of the same items 
included in the ICG, but the words referring to the “dead person” were substituted by 
words referring to the “person/situation” that had been lost due to a stressful event (e.g., 
loss of a job, divorce, loss of health, etc.). Two items were removed because they were 
not pertinent to assessing AD; therefore, the final questionnaire included 17 items. 
Preliminary validation data (Quero, Molés, Mor, Baños & Botella, 2014) showed 
excellent Cronbach coefficients in both general (0.91) and clinical AD (0.86) Spanish 
populations. Test-retest reliability was also excellent (0.90).  
 
Beck Depression Inventory (BDI-II) (Beck Depression Inventory, Beck, Steer & 
Brown 1996; Spanish adaptation by Sanz, Navarro & Vázquez, 2003). This is one of 
the most widely used instruments for assessing depression symptoms. It includes 21 
items, each with four possible answers (0-3). The participants were asked to choose 
which statements best described their mood states in the past 2 weeks. This instrument 
assesses mainly cognitive aspects of depression, along with behavioral and 
physiological symptoms. It establishes 4 quantitative ranges of depression: from 0 to 9 
(absent or minimal), from 10 to 18 (from light to moderate), from 19 to 29 (from 
moderate to severe), and from 30 to 63 (severe). It has high internal consistency (α=.87 
in the general population and α=.89 for the clinical population) (Sanz, García-Vera, 
Espinosa, Fortún, & Vázquez, 2005; Sanz, Perdigón & Vázquez, 2003). 
 
2.3.3. Secondary Outcome Measures 
 Posttraumatic Growth Inventory (PTGI) (Tedeschi & Calhoun, 1996). This 
inventory is composed of 21 items that assess the positive changes that can be 
experienced by people after suffering a traumatic or adverse event, using a 0-5 scale (0 
= “I did not experience this change at all”; 5 = “I experienced this change to a great 
extent”). It includes 5 scales indicating different growth dimensions: related to others (7 
items), new possibilities (5 items), personal strengths (4 items), spiritual changes (2 
items), and life appreciation (3 items). Furthermore, a global score can be calculated by 
adding together the scores obtained on all the responses. High internal consistency 
levels for the 5 scales and for the total score have been found (Tedeschi & Calhoun 
1996; So-kum Tang, 2007, Ho, Wing Chu & Yiu 2008). High scores on this inventory 
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indicate a higher degree of perceived posttraumatic growth. Preliminary data validation 
of the PTGI adaptation in a Spanish clinical sample with AD and CG (Molés, Quero, 
Nebot, Rachyla & López, 2014) showed high internal consistency (0.92) and test-retest 
reliability (0.95). 
Maladjustment Scale (MS) (Adapted from Echeburúa, Corral & Fernández-
Montalvo, 2000). This instrument assesses the level of impairment that the problem and 
its consequences are causing in the patient’s different life areas (work, social life, 
leisure, partner, family, and global impairment), using 0-8 scales where 0 indicates “Not 
impaired” and 8 indicates “severely impaired”. This scale offers good psychometric 
properties, and it is sensitive to the effects of treatment. In the present study, only global 
impairment is presented 
Clinician Severity Scale (Adapted from ADIS-IV Interview by Di Nardo, Brown 
& Barlow, 1994). The therapist makes a global evaluation of the patient’s interference 
and severity on a scale from 0 (“Not impaired or without symptoms”) to 8 (“Severely 
impaired or Very severe symptoms”).  
2.4. Treatment 
The AD-protocol developed by Botella, Baños and Guillén (2008) was 
composed of 6 weekly therapy sessions lasting approximately 1.5 hours each. Two 
additional sessions were optional, depending on the participant’s therapeutic needs. 
Although AD and CG are separate disorders in the ICD-11, they are included in the 
same category of disorders associated with stress. They have common characteristics, 
and so they share similar therapeutic objectives. In this regard, the main aim of the 
treatment applied in this study for both conditions was the reconstruction of meaning 
after loss, in the case of CG, and of the stressful event (e.g., break-up relationship, 
health problems), in the case of AD patients, in order to achieve a more positive 
meaning, thus allowing post-traumatic growth and learning from the negative 
experience. The AD-protocol includes the following therapeutic components.  
1) Psychoeducation 
The patient is provided with information about common reactions to a stressful 
event and a theoretical model that explains how the problems occur and how they are 
maintained. Throughout the treatment sessions, the psychoeducation component is 
aimed at reformulating the patient’s interpretation of difficulties and his/her attitude 
toward problems, teaching more positive ways to manage stressful situations and 
introducing an alternative model explaining the onset and maintenance of AD.  
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2) Exposure, elaboration/processing of the stressful event 
The main objective of this component is to get the person to elaborate on, find 
alternative meanings for, and learn from the stressful experience. This component was 
applied in two ways: 1) Using VR (EMMA’s World). Patients’ narratives of the 
experience are conducted within EMMA’s World (described below), which helps 
participants to evoke, confront, and process the negative emotions associated with the 
negative event, while remaining in a safe virtual space. 2) Traditional format. Patients’ 
narratives of the experience are conducted within a traditional face to face therapy 
context.  
In applying this component, instructions were given to the patient about the 
importance of being aware of emotions, thoughts, and behaviors without judging them. 
The final aim was for the participant to change the negative meaning of the stressful 
event into a more positive one while learning about the negative experience. In vivo 
exposure was also used to confront avoided situations or people related to the stressful 
event. 
3) Strategies from Positive Psychology  
Several strategies from Positive Psychology were included in the protocol in 
order to promote elaboration on, assimilation of, and learning from the experienced 
event. These strategies were the following: 1) “Problem acceptance training” (Popper, 
1995). Lessons about problems as inherent to the human condition were presented to the 
patients. Elements include the usefulness of having problems, the significance of 
problem-solving, and the importance of accepting problems as endemic to the life 
experience. 2) “My best virtues or strengths” exercise (Peterson & Seligman, 2004). In 
this exercise, it is suggested to the patient that virtues give people the strength and 
capacity to cope with life. Examples of virtues are offered to the patient, including 
curiosity, optimism towards the future, sense of humor, etc. Patients have to analyze 
which ones they think they have and which ones they think it would be useful to 
develop and promote in order to cope with their lives. 3) “Heuristics” exercise. From a 
list of heuristics (proverbs, statements, life guidelines), patients choose the ones they 
find helpful in maintaining and promoting the changes achieved in their lives. 
4) Strategies from Neimeyer (2000) 
Several strategies based on Neimeyer’s (2000) suggestions for CG were adapted 
and included in the protocol with the aim of promoting the elaboration/processing of the 
stressful event: 1) The Book of Life (adapted from Neimeyer, 2000). The aim of the 
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book is to help the patient to remember and elaborate on meaningful events that have 
happened with regard to the adverse event. In writing this book, patients can use not 
only words, but also symbols (e.g., pictures, drawings, phrases, etc.). Through this 
process, patients can reflect on the negative situation, the deceased person, the broken 
relationship, etc. The Book of Life is where the patient can reexamine and sort through 
the jumble of memories, thoughts, and emotions that often produce confusion, pain and 
suffering. This process gives the person the opportunity to correct the information that 
was not well stored in his/her memory; that is, the person has the opportunity to rework 
the memories in order to create alternative meanings; 2) the ”Vital trace” exercise. 
Through this exercise patients try to deepen their search for positive aspects of the 
stressful event. According to Neimeyer (2000), people consist of the vestiges of their 
life experiences, both positive and negative, and all of our experiences offer 
opportunities to improve ourselves; 3) Projection letter to the future”. This task requires 
patients to write a letter to themselves from the future. To accomplish this, they first 
spend 10 minutes a day for 2 to 3 days, imagining what kind of person they will be in 
10 years (what they will be doing, where they will live and with whom, what their 
careers will be, etc.), and then they write the letter to themselves in second person (as if 
they were writing to a loved one) from the future. Later analysis of the letter will focus 
on sections that reveal the patient’s ability to see “beyond” the current negative 
situation.  
5) Relapse prevention  
The main objective of this component is to maintain and promote therapeutic 
changes in the future. The therapist reviews the therapeutic objectives achieved by the 
patient so far, makes a summary of the main therapeutic components worked on 
throughout the treatment, and resolves doubts and identifies pending issues to work on 
in the future. 
 
2.5. Description of EMMA’s World 
 
EMMA’s World (Baños et al., 2009; Botella et al., 2006) was developed within a 
European Union project (Engaging Media for Mental Health Applications, IST-200-
39192). It consists of an adaptive VR open system that, because of its flexibility, can be 
used to treat different psychological problems. In the specific case of AD, EMMA’s 
World is used to activate and process the emotions and cognitions related to the stressful 
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event and expose the patients to aspects they have been avoiding, in order to facilitate 
the emotional processing of all the aspects related to the stressful event. The underlying 
logic follows Foa and Kozak’s approach (1986) stating that feared pathological 
structures need to be activated as much as possible in order to fully process the event. 
In EMMA’s World, the experienced stressful event can be “physically” represented to 
the patient using different symbols, such as images, 3-D objects, sounds, music, etc., 
that best reflect the emotions and thoughts related to the experience. Furthermore, 
personal elements that are significant to the patient can be introduced in the system (e.g., 
pictures). An important element is the Book of Life, a virtual book in which the patient 
can compile all of the elements that help him/her to represent the most relevant 
moments, people or situations related to the negative experience. EMMA’s world also 
includes five different pre-defined scenarios or “landscapes”: a desert, an island, a 
threatening forest, a snow-covered town, and meadows. These environments were 
designed to stimulate different emotions (relaxation, elation, sadness, etc.). Their 
specific use depends on the context of the session and can be selected by the therapist in 
real time. The therapist can also modify various aspects of these landscapes in real time 
(e.g., the time of day, whether it is raining or foggy, etc.) with the aim of reflecting and 
enhancing the emotion the user is experiencing, or inducing certain emotions. In sum, 
the different elements included in the system and the landscapes of EMMA’s World are 
designed to help patients confront, accept, and manage the previous emotions and 
negative experiences in their lives, and find and develop new meanings and positive 
emotions, while working in a timeless place and a safe therapeutic context. More 
detailed descriptions of EMMA’s World can be found elsewhere (Baños et al., 2009; 
Baños et al., 2011; Botella et al., 2006; Botella, Quero et al., 2006). 
2.6. Technical aspects 
The following devices were used: two PCs, a large screen on which the 
environment was projected, two projectors, a wireless pad, and a system of speakers. 
These devices were placed in a 5x9 meter room. PC#1 had the graphical output from its 
graphic card connected to two projectors (with a resolution of 1024x768 pixels and a 
power of 2000 lumens). They were used to project the environment on a horizontal 
methacrylate screen measuring 4x1.5 meters, placed in the middle of the room. The 
patient could see the virtual environment, interact with it, and navigate through it using 
the wireless pad. The therapist could control the application and the features of the 
13 
 
virtual environment that were shown to the patient with  PC#2. The sound system 
consisted of several speakers distributed in the room to conform to a 5.1 configuration.  
2.7. Procedure 
All the participants who met the inclusion criteria signed the informed consent to 
participate in the study. Then they underwent two assessment sessions lasting 1.5 hours 
each. In the first assessment session, the diagnosis of AD or CG was confirmed, and 
self-report measures were completed. In the second assessment session, the therapeutic 
goals were established. The randomization of the participants took place after the 
assessment sessions were conducted. Therapists and participants involved in the trial 
were blind to treatment allocation during the assessment. Participants were assigned to 
either the EMMA (N = 18), Traditional (N = 18), or Waiting list control (N = 18) 
conditions based on a computer generated randomization list created by the “Random 
Allocation Software”; version 1.0.  Then participants assigned to the treatment 
conditions were treated in 6 to 8 treatment sessions lasting approximately 1.5 hours 
each, with the only difference being the use of VR for the processing/elaboration of the 
stressful event in the EMMA condition. Participants included in the control condition 
did not receive any intervention during a 6-week period, after which they were assessed 
again and then offered the possibility of receiving one of the two treatment conditions. 
Once the treatment was over, all the participants were assessed again at post-treatment 
and at 6 and 12-month follow-ups.  
Five therapists participated in the study. They had a PhD or a Master’s degree in 
Psychology. All of them were trained in VR techniques and CBT programs for 
Emotional Disorders. In addition, they had received training in this treatment protocol 
by senior clinicians. They were supervised by senior clinicians with PhDs in weekly 
sessions. Moreover, all of the assessment and treatment sessions were video-taped in 
order to supervise the performance of each therapist. 
2.8. Data Analyses 
Group differences at pre-treatment on demographic data and clinical variables 
were evaluated using chi-square tests for categorical variables and one-factor analyses 
of variance (ANOVAs) for continuous data. Intent-to-treat (ITT) mixed models analyses 
without any ad hoc imputation were used to account for missing data (Chakraborty & 
Gu, 2009). A mixed model approach is appropriate for RCTs with multiple time points 
and pre-to post-only designs, it does not assume that the last measurement is stable, and 
it is conducted using all available observations (Gueorguieva, & Krystal, 2004; Salim, 
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Mackinnon, Christensen, & Griffiths, 2008). A linear mixed model for each outcome 
measure was implemented with time (pre and post) as within-group factor and group 
(EMMA, Traditional and WL) as between-group factor using the MIXED procedure 
with a random intercept for subject. Because the random effect had one level, an 
identity covariance structure was specified to model the covariance structure of the 
intercept. Separate mixed-model analyses were performed to examine changes from 
baseline in each intervention at posttest and 6- and 12-month follow-ups. Significant 
effects were followed up with pairwise contrasts. Effect sizes (Cohen’s d) were 
calculated for within- and between-group comparisons, based on Botella and Sánchez-
Meca (2015). Finally, Chi-squared tests were performed based on completers in order to 
examine the differential clinically significant improvement rates, following the 
Jacobson and Truax (1991) indexes, for the primary outcomes scores at post-treatment 
and 6- and 12-month follow-ups in the two treatment conditions just considering those 
participants who completed the treatment protocol. All statistical analyses were 
performed using the IBM SPSS version 23 for Windows.  
3. RESULTS 
3.1. Participant flow and attrition  
Participants were recruited between January 2009 and April 2011. Initially, as 
the flow diagram shows (see Figure 1), 97 people were interested in the study, and 67 of 
them were assessed for eligibility criteria. Thirteen participants were excluded from the 
study for several reasons (see Figure 1). Thus, 54 participants were randomly allocated 
to each experimental condition (EMMA condition, N = 18; Traditional condition, N = 
18; and WL, N = 18). However, during treatment, 8 participants dropped out of the 
study. No significant differences in attrition rates were found at post-treatment between 
conditions. After treatment completion, 1 participant in the traditional condition 
worsened and was excluded from the study. This participant was successfully treated 
years ago for an obsessive-compulsive disorder that reappeared in the follow-up 
assessment period of the present study due to a new stressful situation in his life, and so 
more therapy sessions were needed. Therefore, in this condition, 14 participants 
completed the 6-month follow-up assessment. Finally, at 12-month follow-up, a total of 
24 participants attended the assessment session: 10 participants in the traditional 
condition and 14 in the EMMA condition. Data were missing completely at random 




3.2. Baseline data and participants characteristics 
Baseline analyses showed no significant differences between the three groups at 
pre-treatment on any demographic variables, diagnostic subtype, length of the problem, 
medication intake variables, and outcomes measures, except for the PTGI (F(2,51) 
=5.187, p < .05), where the WL control group scored significantly higher than the two 
treatment conditions (EMMA and Traditional). No variations in the medication were 
produced throughout the study.  
 
3.3. Differential effectiveness of the three experimental conditions: changes in 
outcome measures at pre and post-treatment 
Primary outcomes  
A significant time x group interaction was found for BDI-II (F(2, 46.78) = 3.575, 
p < .05) and ISL/ICG (F(2, 44.36) = 27.898, p < .05). Within-group comparisons 
showed significant reductions on both primary outcome measures for the Traditional 
[BDI: F(1, 47.14) = 22.650, p < .001; ISL/ICG: F(1, 44.21) = 18.385, p < .001] and 
EMMA [BDI:F (1, 47.14) = 17.304, p < .001; ISL/ICG: F(1, 44.21) = 18.129, p < .001], 
conditions, corresponding to large effect sizes (from 1.02 to 1.24), but no significant 
change was found in the WL group (see Table 2). For the BDI-II, between-group 
comparisons revealed that post-treatment scores were significantly lower in the 
Traditional and EMMA groups, compared to WL, with moderate-large effect sizes (-.89 
and -.78, respectively) (see Table 3). For the ISL/ICG, between-group comparisons 
revealed that participants in the Traditional condition scored significantly lower at post-
treatment than the WL, with a large effect size (d = -.92) (see table 3 for details).  
Secondary outcomes  
Regarding PTGI, pre-treatment scores on this measure were entered as a 
covariate to account for baseline differences. Results indicated a significant time x 
group interaction effect (F(2, 44.862) = 13.733, p < .001). Within-group comparisons 
revealed a significant pre-to-post change in the two treatment groups (F(1, 45.112) = 
49.962, p < .001, for both groups), with large effect sizes (from -1.62 to -2.05), and no 
significant change in the WL (table 2). At post-treatment, no statistically significant 
between-group differences were found (Table 3). 
For both the Maladjustment Scale and Clinician Severity Scale, a significant 
time x group interaction was found [(F(2, 48.32) = 5.911, p < .01) (F(2, 25.617) = 
24.088, p< .001), respectively]. Within-group comparisons revealed significant 
16 
 
reductions for both treatments [(Maladjustment Scale, Traditional: F(1, 49.19) = 33.981, 
p < .001; EMMA: F(1, 47.89) = 21.426, p < .001) (Clinician Severity Scale, Traditional: 
F(1, 26.51) = 29.997, p < .001; EMMA: F(1, 24.220) = 93.938, p < .001)], 
corresponding to large effect sizes, but no significant change was found in WL (see 
Table 2). Between-group comparisons showed that post-treatment scores on these 
measures were significantly lower in both treatments compared to WL, achieving large 
effect sizes (from -.81 to -1.94) (Table 3). 
 
3.4. Differential effectiveness of the two treatment conditions: changes in outcome 
measures at pre-, 6-, and 12-month follow-ups 
Separate mixed model analysis for each primary and secondary outcome 
measure yielded no significant time x group interaction effect. Within-group 
comparisons revealed a significant change (from pre- to 6- and 12-month follow-ups, 
respectively) in both treatments for all primary and secondary outcome measures (all ps 
< .001), corresponding to large effect sizes (see table 2 for details). No statistically 
significant differences between the two treatments (EMMA vs. Traditional) were found 
at the 6-month or 12-month follow-up (Table 3). However, larger effect sizes were 
obtained in the EMMA condition at the 12-month follow-up, compared to the 
Traditional condition (see Table 2). 
 
INSERT TABLES 2 AND 3 ABOUT HERE 
 
3.5. Clinically meaningful improvement 
Table 4 shows the percentages of participants in each condition who were 
recovered, improved, had no change, or were impaired, according to the ISL/ICG and 
BDI measures, and based on the classification proposed by Iraurgi (2010) and Kupfer 
(1991). In general, better results were obtained for the primary outcome measure most 
closely related to the problem, the ISL/ICG. At post-treatment, more participants (who 
had completed the treatment) in both conditions were included in the categories 
recovered or improved. Then, the percentage of recovered improved slightly at the 6-
month follow-up in both conditions, but in the long term, more participants in the 
EMMA condition were included in the recovered category, whereas a decrease was 
found in the Traditional condition. In the case of the BDI-II, again significantly more 
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participants were included in the recovered category in the EMMA condition than in the 
Traditional condition.  
INSERT TABLE 4 ABOUT HERE 
4. DISCUSSION 
The main objective of the present study was to test, in a controlled study, the 
long-term efficacy of a CBT protocol for AD and CG in a traditional format versus a 
format supported by VR (EMMA’s World), and compared to a WL control group. First, 
data showed that both treatment conditions resulted in statistically significant 
improvements with large effects sizes on both primary and secondary outcome 
measures, and this improvement did not occur in the WL control condition. Therefore, 
the first hypothesis was confirmed. These data agree with those obtained in previous 
studies (Andreu-Mateu et al., 2012; Baños et al., 2011), and they confirm the usefulness 
of this psychological treatment protocol supported by VR for AD and CG. These results 
are also consistent with the conclusions reported by review studies on the efficacy of 
VR exposure therapy for the treatment of anxiety disorders: systematic reviews (Gregg 
& Tarrier, 2007; McCann et al., 2014; Meyerbroker & Emmelkamp, 2010) and meta-
analyses (Morina et al., 2015; Opriş et al., 2012; Parsons & Rizzo, 2008; Powers & 
Emmelkamp, 2008), and by meta-analytic studies specifically addressing the use of VR 
for stress-related disorders (Botella, Serrano, Baños & Garcia-Palacios, 2015; 
Gonçalves, Pedrozo, Coutinho, Figueira & Ventura, 2012; Motraghi, Seim, Meyer & 
Morissete, 2014). Finally, our results are also consistent with those obtained in studies 
on the traditional treatment for AD (Andrews, 1995; Araoz & Carrese, 1996; Benton & 
Lynch, 2005, Strain, 1995; van der Klink, et al., 2003) and CG (Neimeyer, 2000).  
Second, as expected, no statistically significant differences were found between 
the two treatment groups at any assessment moment. However, at the 12-month follow-
up, additional improvements were observed in the EMMA condition, with larger effect 
sizes in the long term, compared to the Traditional condition (see Table 2). Similarly, 
results for clinically significant change estimations indicated an advantage for the 
EMMA condition on the primary outcome measures (ISL/ICG and BDI), with the 
percentage of recovered participants being significantly higher at 12-month follow-up in 
this condition, compared to the traditional one. In any case, it is important to point out 
that scores on the BDI-II were not very high at pre-treatment. Therefore, the second 
hypothesis was partially confirmed. 
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Finally, as hypothesized, significant improvements achieved in both treatments 
for all primary and secondary outcome measures were maintained in the medium (6-
month) and long term (12-month).  
Based on the results obtained in the present study, we can conclude that both 
treatment conditions were effective at post-treatment, but the EMMA condition was 
slightly superior on the outcome measures and the clinically meaningful change in the 
long term. Furthermore, results obtained from 18 patients included in this study  (7 from 
the traditional condition and 11 from the EMMA condition) after treatment, showed that 
66.7% of them preferred the VR condition, whereas only 33.6% preferred the traditional 
one.  Our data indicate a preference for the EMMA system, but this result cannot be 
generalized to all patients since the sample size was small. Moreover, it should be kept 
in mind that these patients were willing to receive psychological treatment supported by 
VR, and not all patients would necessarily have a positive opinion about technologies. 
On the other hand, in the case of these problems, the positive results obtained in the 
long term are especially relevant, considering the few studies available in the literature 
about the maintenance of therapeutic gains. Results from this study offer additional 
support for the positive and lasting effects of VR in the psychological treatment field 
(e.g., Botella et al., 2007; Emmelkamp et al., 2002; Rothbaum, Hodges, Anderson, 
Price & Smith, 2002; Ready, Pollack, Rothbaum & Alarcón, 2006). Other advantages of 
the VR environment used in the present study should be pointed out. First, as mentioned 
in the introduction, EMMA’s World adapts its contents in relation to the affective 
manifestations the users express at any time during the therapy session, resulting in the 
creation of a personalized and clinically meaningful environment, which, in turn, favors 
the complete immersion in the narrative and the elaboration and assimilation of the 
events. Second, the system uses symbols, landscapes and other personalized elements to 
create a context that “represents or symbolizes” the situation. The use of VR and 
symbols to conduct exposure/elaboration provides a safe context where patients can 
experience and confront their problems without the inconvenience of real life. In fact, 
patients perceive VR exposure to be less aversive than the traditional exposure 
technique (Baños et al., 2009; Botella et al., 2016).  
In summary, this study follows along the lines of existing literature supporting 
the use of technology (in this case VR) in the field of psychological treatments 
(Freeman et al. 2017) because, as the data point out, information and communication 
technologies can improve psychological treatments by providing a cost-effective way to 
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deliver empirically validated treatments for a variety of psychological problems 
(Newman et al., 2011), in this case AD. Undoubtedly, this work contributes to 
achieving the crucial revolution anticipated through the use of VR in the mental health 
field (Freeman et al., 2017; Linder et al., 2017). Indeed, studies like the present one 
indicate that this revolution is already underway.  
However, the present study has some limitations that should be highlighted. First, 
the sample size was small and most of the participants had university degree, limiting 
the generalization of the results. The level of education seems to be well above average, 
which might also limit the generalizability of the results. On the other hand, as 
mentioned before, for the diagnosis DSM-IV-TR and ICD-10 criteria were followed in 
the present study, and the diagnostic interview for AD is currently under validation 
process. The Diagnostic Interview for Adjustment Disorder (DIAD) (Comelius et al., 
2014) could not be used because it was not available at the time the study was 
conducted. In addition, it would have been desirable to include an anxiety measure as a 
primary outcome. Finally, all participants received the complete AD-protocol, and so is 
not possible to determine the specific contribution of each therapeutic component to the 
patients’ improvement. Related to this, future studies should consider evaluating 
whether AD and CG patients differ in their response to this treatment protocol, in order 
to detect the need to tailor the treatment to each stress-related disorder included in the 
present study.  
A future guideline in the field of using technology to improve psychological 
interventions in AD and CG is the use of the Internet to complement the therapy. 
Preliminary data are already available on the usefulness of an online emotion regulation 
system (TEO) to apply homework assignments over the Internet in treating AD (Quero, 
Molés, Pérez-Ara, Botella & Baños, 2012). This system allows patients to practice the 
elaboration/processing of the stressful event at home during the period between sessions. 
A system such as TEO offers great adaptability and flexibility in adjusting the 
therapeutic homework to each patient’s characteristics and needs, focusing on the 
specific significance of his/her problem. 
To conclude, the results obtained in the present study have contributed to 
increasing the knowledge and available resources to deal with AD and CG. It is the first 
controlled study to compare an AD-protocol applied face-to-face to the same protocol 
supported by VR and a waiting list control group in the treatment of these stress-related 
disorders. The possibility of having an effective treatment protocol is particularly 
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relevant in the AD field, considering the few controlled studies found in the literature 
about AD treatment, in addition to its high prevalence (Carta et al., 2009), the 
impairment in social and work functioning associated with this problem (Van der Klink 
et al., 2003), the potential AD has of presenting life-threatening features (Casey et al., 
2015), and in the long term, the burden for the individual, his/her work place, society, 
and the economy (Lagerveld et al., 2012).  
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Table 1. Participants’ descriptive data about demographic variables, and diagnosis variables. 




(N = 18) 
TRAD 
(N = 18) 
WL 
(N = 18) 
Total  




Range 21-49 18-42 21-50 18-50 




Men 4 (22.2%) 7 (38.9%) 3 (16.7%) 14 (25.9%) 
Woman 14 (77.8%) 11 (61.1%) 15 (83.3%) 40 (74.1%) 
Marital status       
Single 7 (38.9%) 11 (61.1%) 8 (44.4%) 26 (48.1%) 
Married/ partnered 7 (38.9%) 7 (38.9%) 7 (38.9%) 21 (38.9%) 
Divorced/separated/widower 4 (22.2%) 0 (0%) 3 (16.7%) 7 (13%) 
Level of studies 
  
  
Elementary/High  school 3 (16.7%) 5 (27.8%) 6 (33.3%) 14 (25.9%) 







With depressed mood 2 (11.1%) 3 (16.7%) 2 (11.1%) 7 (13%) 
With anxiety  0 (0%) 1 (5.6%) 1 (5.6%) 2 (3.7%) 
With mixed anxiety and 
depressed mood 
15 (83.3%) 12 (66.7%) 11 (61.1%) 38 (70.4%) 
With disturbance of conduct 0 (0%) 0 (0%) 1 (5.6%) 1 (1.9%) 
CG 1 (5.6%) 2 (11.1%) 3 (16.7%) 6 (11.1%) 
Length of the problem     
Range (months to years) 3 to 20 3 to 17 5 to 10 3 to 20 
Years mean (SD)  4.37 (5.29) 3.11 (4.02) 3.51 (3.38) 3.66 (4.26) 
Medication (anxiolytics 
and/or antidepressants) 
    
Yes 26.7% 6.7% 31.3% 21.7% 
No 73.3% 93.3% 68.8% 78.3% 
Note: SD = Standard Deviation; EMMA = EMMA Intervention group; TRAD= Traditional 
Intervention group; WL = Waiting list control group; AD = Adjustment disorder; CG = 















Pre vs. Post Pre vs. 6-month FW Pre vs. 12 month FW 
  Mean (SD) Mean (SD) Mean (SD) Mean (SD) d (95% CI) d (95% CI) d (95% CI) 
ISL/ICG         
 TRAD 35.72 (16.88) 17.67 (7.10) 13.71 (9.49) 11.00 (7.56) d=1.02 (.55, 1.50) d=1.25 (.59, 1.90) d=1.40 (.59, 2.21) 
 EMMA  36.33 (13.05) 19.40 (13.87) 13.53 (12.63) 5.86 (5.38) d=1.24 (.48, 2.00) d=1.67 (.81, 2.52) d=2.23 (1.08, 3.38) 
 WL 31.25 (15.93) 28.53 (14.53)   d=.16 (-.25, .58)   
BDI-II         
 TRAD 23.00 (10.48) 10.40 (7.71) 8.93 (9.55) 8.70 (9.43) d=1.15 (.40, 1.89) d=1.28 (.57, 1.99) d=1.30 (.58, 2.02) 
 EMMA  23.00 (9.41) 11.87 (6.77) 7.93 (6.41) 4.21 (7.37) d=1.13 (.40, 1.86) d=1.53 (.80, 2.26) d=1.91 (.93, 2.89) 
 WL 23.17 (11.48) 19.88 (12.40)   d=.16 (-.09, .40)   
PTGI         
 TRAD 30.72 (15.39) 63.67 (18.88) 58.64 (19.26) 61.30 (16.95) d=-2.05 (-3.01, -.08) d=-1.73 (-2.59, -.87) d= -1.57 (-2.42, -.72) 
 EMMA  29.50 (18.61) 61.13 (24.10) 56.00 (21.71) 63.29 (19.19) d=-1.62 (-2.33, -.92) d=-1.36 (-2.02, -.70) d=-1.73 (-2.53, -.94) 
 WL 49.28 (26.37) 51.75 (29.73)   d=-.09 (-.30, .12)   
Impairment         
 TRAD 5.78 (1.00) 3.21 (1.81) 2.36 (1.34) 2.00 (1.41) d=2.45 (1.44, 3.46) d=3.27 (1.92, 4.62) d=.3.61 (2.05, 5.18) 
 EMMA  5.83 (1.15) 3.80 (.86) 2.00 (1.73) 1.43 (1.28) d=1.69 (.71, 2.66) d=3.18 (1.79, 4.57) d=3.65 (2.19, 5.12) 
 WL 5.83 (1.38) 5.33 (2.44)   d=.35 (-.07, .77)   
Severity          
 TRAD 5.41 (1.12) 3.17 (.75) 2.33 (1.53) 1.33 (.578) d=1.91 (1.01, 2.81) d=2.63 (1.43, 3.82) d=3.48 (2.05, 4.91) 
 EMMA  5.59 (.62) 2.70 (1.06) 2.33 (.58) 1.25 (.50) d=4.45 (2.79, 6.11) d=5.02 (3.12, 6.93) d=6.69 (4.18, 9.20) 
 WL 4.82 (1.51) 5.29 (1.50)   d=-.30 (-.55, -.04)   
Note: Mean and standard deviations (SD) are represented. Pre= Pre-treatment. Post= Post-treatment. FW= Follow-up. d = Cohen’s d. CI= Confidence Interval. EMMA = 
EMMA Intervention group; TRAD= Traditional Intervention group; WL = Waiting list control group; ISL= Inventory of Stress and Loss; ICG= Inventory of Complicated 
Grief; BDI-II= Beck Depression Inventory II; PTGI= Posttraumatic Growth Inventory; Impairment= Maladjustment Scale; Severity= Clinician Severity Scale. 
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Table 3. Between-group comparisons at post-treatment and 6- and 12-month follow-Up.  
 





d (95% CI) 
Mean 
diff. 
d (95% CI) 
Mean 
diff. 
d (95% CI) 
SLI/ICG        
 TRAD vs. WL -10.38* d = -.92 (-1.68, -.17)     
 EMMA vs. WL -9.65 d = -.63 (-1.36, .11)     
 EMMA vs. TRAD .74 d = .15 (-.56, .87) -.96 d = -.02 
 (-.74, .71) 
-5.27 d = -.78  
(-1.62, .06) 
BDI-II        
 TRAD vs. WL -9.07* d = -.89 (-1.64, -.14)     
 EMMA vs. WL -7.53* d = -.78 (-1.52, -.04)     
 EMMA vs. TRAD 1.53 d = .20 (-.52, .91) -1.19 d = -.12  
(-.84, .61) 
-4.75 d = -.58  
(-1.41, .24) 
PTGI        
 TRAD vs. WL 12.43 d = .47 (-.26, 1.19)     
 EMMA vs. WL 9.13 d = .34 (-.37, 1.06)     
 EMMA vs. TRAD -3.30 d = -.11 (-.82, .61) -1.55 d = -.12  
(-.85, .60) 
2.24 d = .11 
 (-.70, .92) 
Impairment        
 TRAD vs. WL -2.06*** d = -.96 (-1.72, -.20)     
 EMMA vs. WL -1.43** d = -.81 (-1.56, -.07)     
 EMMA vs. TRAD .62 d = .41 (-.32, 1.13) -.30 d = -.23 
 (-.96, .51) 
.51 d = -.41 
 (-1.23, .41) 
Severity         
 TRAD vs. WL -1.64** d = -1.74 (-2.58, -.90)     
 EMMA vs. WL -2.25*** d = -1.94 (-2.81, -1.07)     
 EMMA vs. TRAD -.62 d = -.50 (-1.22, .23) .072 d = .00  
(-.73, .73) 
.53 d = -.14 
 (-.96, .67) 
Note: d = Cohen’s d. Values between () represents the 95% Confidence Interval. Mean diff.= Mean differences. * p < .05, ** 
p < .01, *** p < .001. EMMA = EMMA Intervention group; TRAD= Traditional Intervention group; WL = Waiting list 
control group; ISL= Inventory of Stress and Loss; ICG= Inventory of Complicated Grief; BDI-II= Beck Depression Inventory 




Table 4. Clinically Meaningful Improvement on the ISL/ICG and BDI at Post-treatment, 6 
and 12 month follow up.  
 
             Post-treatment                 6-month FW                 12-month FW 
Measures EMMA TRAD   EMMA TRAD   EMMA TRAD 
ISL/ICG  
        
Recovered 10 (71.4%) 10 (66.7%) 
 
12 (85.7%) 11 (84.6%) 
 
13 (100%) 7 (70%) 
Improved 0 (0%) 0(0%) 
 
0 (0%) 0(0%) 
 
0 (0%) 0 (0%) 
No change 4 (28.6%) 5 (33.3%) 
 
2 (14.3%) 2 (15.4%) 
 
0 (0%) 3 (30%) 
Impaired 0 (0%) 0 (0%)    0 (0%) 0 (0%)   0 (0%) 0 (0%) 
BDI-II 
        
Recovered 4 (26.7%) 6 (40%) 
 
8 (53.3%) 6 (42.9%) 
 
10 (71.4%) 3 (30%) 
Improved 1 (6.7%) 0 (0%) 
 
1 (6.7%) 1 (7.1%) 
 
0 (0%) 0 (0%) 
No change 10 (66.7%) 9 (60%) 
 
6 (40%) 7 (50%) 
 
4 (28.6%) 7 (70%) 
Impaired 0 (0%) 0(0%) 
 
0 (0%) 0 (0%) 
 
0 (0%) 0 (0%) 
 
